期刊文献+

乙型肝炎病毒耐药的研究进展 被引量:7

Drug resistance of hepatitis B virus
下载PDF
导出
摘要 核苷(酸)类似物已成为继干扰素-α之后的又一类用于抗乙型肝炎病毒治疗的有效药物,但是长时间服用核苷(酸)类似物易出现耐药。本文对核苷(酸)类似物耐药的发生机制、耐药后的补救治疗、耐药的预防等内容作一简介,以供临床参考。 Nucleotide analogues have been an another type of effective antiviral drugs besides intefferon-et for treatment hepatitis B, but drug resistance will be developed after long-term therapy. Here, a brief introduction about the mechanism, the rescue therapy and the prevention of drug resistance is presented in this paper for clinical consultation.
作者 吴淑玲 成军
出处 《胃肠病学和肝病学杂志》 CAS 2008年第9期771-773,共3页 Chinese Journal of Gastroenterology and Hepatology
关键词 乙型肝炎病毒 耐药 Hepatitis B virus Drug resistance
  • 相关文献

参考文献3

二级参考文献9

  • 1Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association. 42 Dongsi Xidajie,Beijing 100710,China.慢性乙型肝炎防治指南[J].中华肝脏病杂志,2005,13(12):881-891. 被引量:1931
  • 2Lok AS, McMahon B J; Practice Guidelines Committee, American Association for the Study of Liver Diseases (AASLD). Chronic hepatitis B: update of recommendations. Hepatology, 2004, 39: 857-861.
  • 3Liaw YF, Leung N, Guan R, et al. Asian-Pacific consensus statement on the management of chronic hepatitis B: an update. J Gastroenterol Hepatol, 2003, 18: 239-245.
  • 4Mangi A, Villani MR, Minerva N, et al. Efficacy of 5MU of interferon in combination with ribavirin for naive patients with chronic hepatitis C virus: a randomized controlled trial. J Hepatol, 2001,34: 441-446.
  • 5Berg T, Sarrazin C, Herrmann E, et al. Prediction of treatment outcome in patients with chronic hepatitis C: significance of baseline parameters and viral dynamics during therapy. Hepatology, 2003,37: 600-609.
  • 6Strader DB, Waright T, Thomas DL, et al. Diagnosis, management,and treatment of hepatitis C. Hepatology, 2004, 39: 1147-1171.
  • 7Gauthier J, Bourne EJ, Lutz MW, et al. Quantitation of hepatitis Bviremia and emergence of YMDD variants in patients with chronic hepatitis B treated with lamivudine. J Infect Dis, 1999, 180: 1757-1762.
  • 8Yuen MF, Sablon E, Hui CK, et al. Factors associated with hepatitis B virus DNA breakthrough in patients receiving prolonged lamivudine therapy. Hepatology, 2001, 34: 785-791.
  • 9Jang JW, Bae SH, Chio JY, et al. Early virological response predicts outcome during extended lamivudine retreatment in patients with chronic hepatitis B who relapsed after initial HBeAg response. J Gastroenterol Hepatol, 2006, 21: 384-391.

共引文献409

同被引文献86

引证文献7

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部